Company profile
Deltagen Inc.
OTC: DGEN · Healthcare · Medical - Instruments & Supplies
#986 of 1,422 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 47
v0.1 · 5/100 weight · pillars only
↑ operating margin, balance-sheet leverage · ↓ market scale, revenue growth (YoY)
Methodology →Revenue TTM
$5.1M
Rev growth YoY (TTM)
-65.8%
Net income (FY)
$76.0k
Employees
—
as of 2026-08-30
Market cap
$3.9k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$263.0k$263.0k2014
Net income$76.0k$76.0k2014
Operating income$77.0k$77.0k2014
Total assets$1.8M$1.8M2014
Liabilities$124.0k$124.0k2014
Equity$1.7M$1.7M2014
Revenue trend
FY2006 – FY2014 · USD
FY06
FY07
FY08
FY09
FY10
FY12
FY13
FY14
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Deltagen Inc.’s revenue?
Deltagen Inc. booked $263.0k in FY2014 revenue, contracting 74% year over year — slower than 87% of Healthcare companies we track, at a 28.9% net margin.
Neighbors
San Mateo →Key facts
CEORobert J. Driscoll
SectorHealthcare
IndustryMedical - Instruments & Supplies
HeadquartersSan Mateo, CA
ExchangeOTC: DGEN
Employees—
IPO date2000-08-03
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.